Major proteins of bovine seminal plasma modulate sperm capacitation by high-density lipoprotein.
Bovine seminal plasma (BSP) contains four similar proteins secreted by the seminal vesicles, designated BSP-A1, -A2, -A3, and -30 kDa. These proteins bind to choline phospholipids on the surface of the sperm after ejaculation. These BSP proteins also interact with heparin, apolipoprotein A-I (apoA-I) and apoA-I associated with high-density lipoprotein (HDL). The HDL and heparin present in the female reproductive tract have been implicated in sperm capacitation and the acrosome reaction (AR). This study was undertaken to determine whether or not these BSP proteins and HDL could modulate the capacitation of sperm, and to determine the combined effect of HDL and heparin on capacitation. Washed bovine epididymal sperm were preincubated in buffer containing BSP proteins, washed, and incubated with lipoproteins (HDL, and low- and very low-density lipoproteins) or liposomes with or without apoA-I in the presence or absence of heparin. The percentage of capacitated sperm was evaluated after the AR was induced with lysophosphatidylcholine. HDL alone (160 microg/ml) after an 8-h incubation stimulated the AR of epididymal sperm. The percentage of HDL-enhanced AR further increased when sperm were preincubated with BSP proteins. ApoA-I-liposomes stimulated the AR more rapidly (5 h, 160 microg/ml) than HDL. When sperm were preincubated with BSP proteins, the percentage of apoA-I-enhanced AR further increased. In contrast, when liposomes without apoA-I or when low- or very low-density lipoproteins or lipoprotein-depleted serum was used, no significant increase in the AR was detected with or without BSP proteins. When heparin and HDL or apoA-I-liposomes were used together, their combined effects on the AR were not additive. These results indicate that BSP proteins modulate the process of capacitation induced by heparin, HDL, and apoA-I-liposomes.
Thérien
I
I
Department of Medicine, University of Montreal and Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, Quebec, Canada.
Soubeyrand
S
S
Manjunath
P
P
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D016632:Apolipoprotein A-I / Q000378:metabolism; D001798:Blood Proteins / Q000737:chemistry / Q000494:pharmacology*; D002417:Cattle; D004396:Coloring Agents; D003470:Culture Media; D004822:Epididymis / Q000166:cytology; D005260:Female; D006493:Heparin / Q000494:pharmacology; D066298:In Vitro Techniques; D008075:Lipoproteins, HDL / Q000302:isolation & purification / Q000494:pharmacology*; D008081:Liposomes; D008297:Male; D012661:Semen / Q000737:chemistry*; D013075:Sperm Capacitation / Q000187:drug effects*
D000925:Anticoagulants; D016632:Apolipoprotein A-I; D001798:Blood Proteins; D004396:Coloring Agents; D003470:Culture Media; D008075:Lipoproteins, HDL; D008081:Liposomes; D006493:Heparin